Wilk
Wilk is an Israeli bio-foodtech company that produces cell-cultured human and animal milk, milk fat, and milk proteins from mammary epithelial cells in bioreactors, targeting infant nutrition, dairy, pharma, and cosmetics applications through B2B licensing and strategic partnerships.
- Company typePublic
- Founded2020
- HeadquartersRehovot, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wilk does
Wilk Technologies Ltd. is an Israeli bio-foodtech company that develops cell-cultured milk and milk components produced from mammalian mammary epithelial cells cultivated in bioreactors. The company produces cultured human breast milk (targeted at infant nutrition including preterm newborns), cultured animal milk for conventional dairy applications, and discrete high-value ingredients including cell-cultured milk fat (used in the world's first cell-based yogurt, validated by external labs in November 2022) and human lactoferrin proteins (produced in laboratory testing in 2022). Its technology is anchored in over a decade of proprietary research and protected by U.S. and other patents on laboratory milk production methods and systems.
The company operates as a B2B enterprise technology provider targeting the dairy industry, infant nutrition sector, and adjacent industries (pharmaceuticals and cosmetics) through strategic co-development partnerships and technology licensing. The most significant commercial validation is a strategic investment round in April 2023 led by Danone, with participation from Steakholder Foods (2.5% equity stake for $450,000) and Central Bottling Co. Ltd. Wilk is publicly listed on the Tel Aviv Stock Exchange (ticker: WILK) and is headquartered in Rehovot, Israel. The leadership team comprises CEO Ezra Ella (PhD, Hebrew University), CFO Moran Attar (CPA, prior CFO roles at Tel Aviv/Nasdaq/LSE-listed companies), and CSO Nurit Argov-Argaman, PhD (senior lecturer at Hebrew University with 15 years of lactation physiology research). At ~11-50 employees with cumulative disclosed funding of approximately $1.45M and no reported revenue, Wilk is positioned at the pre-commercial platform-validation stage of the alternative-dairy value chain.
Wilk firmographics
Firmographics- Name
- Wilk
- Legal name
- WILK TECHNOLOGIES LTD.
- Website
- https://wilkismilk.com
- Company type
- Public
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Wilk is an Israeli bio-foodtech company that produces cell-cultured human and animal milk, milk fat, and milk proteins from mammary epithelial cells in bioreactors, targeting infant nutrition, dairy, pharma, and cosmetics applications through B2B licensing and strategic partnerships.
- Ownership category
- akta.pro rank
Wilk industry classification
Industry- Product category
- Cell-Cultured Dairy
- NAICS
- Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
- SIC
- Dairy Products (2020)
- akta.pro primary industry
- Cultivated (Cell-Based) Protein Foods Manufacturing (AFAKAGAI)
- akta.pro secondary industries
- Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh) (AFAKAKAC), Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt) (AFAKAKAH), Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing (AFAHADAJ)
Keywords
Where Wilk is headquartered
LocationHeadquarters
- HQ city
- Rehovot
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Wilk business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Cell-based Milk Ingredients: Wilk produces and sells cell-based milk and milk components for various applications including breastfeeding milk for babies, daily dairy consumption, healthy diets, and milk nutritional components for Pharma and Cosmetics industries.
- Technology Licensing and Partnerships: The company generates revenue through strategic partnerships with major food industry players, licensing its cell-based milk production technology to partners like Danone and Steakholder Foods.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Wilk product offering
Product offeringCore offering
Wilk develops cell-cultured milk and milk components by cultivating mammary epithelial cells from humans and animals in bioreactors. The company's product portfolio includes cell-based human breast milk, cell-based animal milk, cultured milk fat, cell-based yogurt, and human lactoferrin proteins, serving the dairy, infant nutrition, pharmaceutical, and cosmetics industries.
Product overview
Wilk is a developer of authentic, cell-cultured human and animal milk and milk components. The company produces a portfolio of products including cell-based human breast milk for infants (including personalized options for preterm babies), cell-based animal milk for dairy consumption, and key milk ingredients like cultured milk fat and human lactoferrin proteins. Wilk's technology enables the production of real milk through cells without relying on animals, maintaining the nutritional profile of conventional milk while addressing sustainability and supply challenges. The company achieved a world first by developing yogurt made with cell-cultured milk fat. All products are produced in laboratory settings using proprietary cell culture technology based on over ten years of research.
Differentiator
Problem solved
Functional benefit
Products and services
- Cell-Based Milk (Human) Cultured human breast milk produced from mammary epithelial cells, providing personalized nutrition for infants including preterm babies, with all the nutritional benefits of natural breast milk.
- Cell-Based Milk (Animal) Cultured animal milk produced from mammary epithelial cells for daily dairy consumption, offering sustainable dairy production without reliance on traditional farming.
- Cell-Cultured Milk Fat Milk fat produced through cell culture technology, used as an ingredient in dairy products like yogurt, maintaining nutritional properties of conventional milk fats.
- Cell-Based Yogurt World's first yogurt developed with cell-cultured milk fat, validated by external laboratories meeting necessary chemical and biological requirements.
- Human Lactoferrin Proteins Breast milk proteins successfully produced in laboratory settings through cell-based technology, offering potential solutions for infant nutrition including baby formula.
- Personalized Milk Ingredients Fully sterile and independent cell-based milk ingredients that can be customized for nutritional, sensory, and therapeutic needs, produced safely in laboratory environments.
Quantifiable outcome
- 1L of conventional milk requires 1,000L of water; Cell-based production dramatically reduces water consumption
- +2 more outcomes
Companies that use Wilk
Customer profileSegments3 records
Ideal customer profiles3 records
Wilk technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Wilk partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
Wilk competitors and assessment
Company assessmentDirect peers
- Perfect Day: Perfect Day is the leading cell-based dairy protein company, producing animal-free whey and casein proteins via precision fermentation. It is the most direct competitor to Wilk in cellular dairy, having raised hundreds of millions from investors including Danone-adjacent capital and partnering with major CPG brands.
- Remilk: Remilk is an Israeli cell-cultured milk company developing animal-free milk proteins using precision fermentation. It is a geographically and technologically comparable peer to Wilk, both pursuing the same end product (cell-based milk) via different production methods.
- TurtleTree Labs: TurtleTree Labs is a Singapore-based cellular agriculture company developing cell-cultured milk, including human breast milk components. It directly competes with Wilk in the cell-based human milk ingredient space and targets similar infant nutrition and dairy applications.
- Biomilq: Biomilq is a US-based cell-cultured human breast milk company using mammary cell technology. It directly competes with Wilk in the cell-based human breast milk and lactoferrin ingredient space, targeting infant nutrition applications.
Emerging players
- The EVERY Company (formerly Clara Foods): The EVERY Company produces animal-free proteins via precision fermentation, originally focused on egg proteins and now expanding into dairy proteins. It represents an emerging competitor in cell-based food proteins with broader protein category coverage than Wilk.
- Steakholder Foods: Steakholder Foods is an Israeli cellular agriculture company developing 3D-printed cultivated meat. It is both a strategic investor in Wilk (2.5% stake for $450K) and a peer in the broader cellular agriculture space, with shared technology synergies in biotechnology and printing.
- Imagindairy: Imagindairy is an Israeli precision fermentation company producing animal-free dairy proteins. It is a geographically and technologically comparable emerging peer to Wilk, focused on cell-based milk proteins via a different production modality.
- Future Fields: Future Fields is a Canadian cellular agriculture company developing bioprocess infrastructure (growth media) for cell-based food production. It serves as an enabling technology peer, supplying tools to cellular agriculture companies including Wilk's broader competitive set.
- Formo: Formo is a German precision fermentation company producing animal-free cheese proteins. While focused on cheese vs. Wilk's milk and yogurt, Formo represents an emerging player in the broader cell-based dairy category targeting similar B2B ingredient opportunities.
Broad incumbents
- Danone: Danone is a global dairy and nutrition incumbent that led Wilk's April 2023 strategic investment round. As both an investor and a broad dairy incumbent, Danone is a key strategic partner and potential customer for Wilk's cell-based milk technology, while also representing the conventional dairy competition Wilk aims to disrupt.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Wilk social profiles
Digital presenceWilk financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wilk leadership team
Management profileNumber of profiles
Profiles3 records
Wilk funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wilk M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wilk
What does Wilk do?
Wilk develops cell-cultured milk and milk components by cultivating mammary epithelial cells from humans and animals in bioreactors. The company's product portfolio includes cell-based human breast milk, cell-based animal milk, cultured milk fat, cell-based yogurt, and human lactoferrin proteins, serving the dairy, infant nutrition, pharmaceutical, and cosmetics industries.
Is Wilk a public or private company?
Wilk is a public company. It is classified as public and is currently operating.
When was Wilk founded?
Wilk was founded in 2020. It employs 11 to 50 people.
Where is Wilk based?
Wilk is headquartered in Rehovot, Israel, in the Middle East region.
How does Wilk make money?
Two revenue lines are on record. Cell-based Milk Ingredients are the primary driver. The others are technology Licensing and Partnerships.
Who are Wilk's main competitors?
Direct peers on record are Perfect Day, Remilk, TurtleTree Labs and Biomilq. Emerging players are The EVERY Company (formerly Clara Foods), Steakholder Foods, Imagindairy, Future Fields and Formo. Danone is listed as a broad incumbent.
Does Wilk have an API?
No public API is recorded for Wilk.
What industry is Wilk in?
Wilk's product category is Cell-Cultured Dairy. Its primary akta.pro industry code is AFAKAGAI, Cultivated (Cell-Based) Protein Foods Manufacturing, with a secondary code of AFAKAKAC, Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh). Its NAICS code is 3115 and its SIC code is 2020.